Last reviewed · How we verify
NCT04640883
Effects of Including Sprints During Low-intensity Cycling Exercises on Performance and Muscle/Blood Characteristics
NA trial testing Inclusion of sprints during low-intensity cycling during a 14-day training camp (high training load) in Healthy in 18 participants. Completed in 23 December 2017.
23 December 2017
Quick facts
| Lead sponsor | Inland Norway University of Applied Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 18 |
| Start date | 23 October 2017 |
| Primary completion | 23 December 2017 |
| Estimated completion | 23 December 2017 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Inclusion of sprints during low-intensity cycling during a 14-day training camp (high training load)
- Low-intensity cycling during a 14-day training camp (high training load)
- Recovery for 10 days (low training load)
Conditions studied
Sponsor
Inland Norway University of Applied Sciences
Who can join
Adults 18 to 40, male only, with Healthy or Cyclists. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the effects of Including 30-s sprints during low-intensity cycling exercises during a training camp on performance and muscle/blood characterisitcs in elite cyclists
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04640883
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Inland Norway University of Applied Sciences trials
Trials by the same sponsor.
- NCT07159815 — REACT - Resistance Exercise After Cancer Treatment · NA · recruiting
- NCT06611566 — VR-guided Exercise and Mindfulness Program for People with Chronic Pain · NA · completed
- NCT04637178 — Predicting the Efficacy of Resistance Exercise Training for Improving Endurance Performance · NA · completed
- NCT04611646 — Effects of Heat-suit Training on Biological and Performance Characteristics in Elite Cyclists · NA · completed
- NCT04545190 — RibOSE - Glucose and Resistance Exercise Training · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04640883 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inland Norway University of Applied Sciences
- Last refreshed: 23 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04640883.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing